• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿什肯纳兹犹太裔 BRCA1 和 BRCA2 突变携带者中的单体型结构。

Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers.

机构信息

Center for Cancer Research, Cancer Inflammation Program, Human Genetics Section, National Cancer Institute, Frederick, MD, USA.

出版信息

Hum Genet. 2011 Nov;130(5):685-99. doi: 10.1007/s00439-011-1003-z. Epub 2011 May 20.

DOI:10.1007/s00439-011-1003-z
PMID:21597964
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3196382/
Abstract

Three founder mutations in BRCA1 and BRCA2 contribute to the risk of hereditary breast and ovarian cancer in Ashkenazi Jews (AJ). They are observed at increased frequency in the AJ compared to other BRCA mutations in Caucasian non-Jews (CNJ). Several authors have proposed that elevated allele frequencies in the surrounding genomic regions reflect adaptive or balancing selection. Such proposals predict long-range linkage disequilibrium (LD) resulting from a selective sweep, although genetic drift in a founder population may also act to create long-distance LD. To date, few studies have used the tools of statistical genomics to examine the likelihood of long-range LD at a deleterious locus in a population that faced a genetic bottleneck. We studied the genotypes of hundreds of women from a large international consortium of BRCA1 and BRCA2 mutation carriers and found that AJ women exhibited long-range haplotypes compared to CNJ women. More than 50% of the AJ chromosomes with the BRCA1 185delAG mutation share an identical 2.1 Mb haplotype and nearly 16% of AJ chromosomes carrying the BRCA2 6174delT mutation share a 1.4 Mb haplotype. Simulations based on the best inference of Ashkenazi population demography indicate that long-range haplotypes are expected in the context of a genome-wide survey. Our results are consistent with the hypothesis that a local bottleneck effect from population size constriction events could by chance have resulted in the large haplotype blocks observed at high frequency in the BRCA1 and BRCA2 regions of Ashkenazi Jews.

摘要

BRCA1 和 BRCA2 中的三个 founder 突变导致阿什肯纳兹犹太人(AJ)中遗传性乳腺癌和卵巢癌的风险增加。与非犹太裔白种人(CNJ)中的其他 BRCA 突变相比,它们在 AJ 中的出现频率更高。一些作者提出,周围基因组区域中升高的等位基因频率反映了适应性或平衡选择。这些提议预测了由于选择性清除而导致的长程连锁不平衡(LD),尽管创始人群体中的遗传漂变也可能导致长距离 LD 的产生。迄今为止,很少有研究使用统计基因组学工具来研究在经历遗传瓶颈的人群中有害基因座的长程 LD 的可能性。我们研究了来自 BRCA1 和 BRCA2 突变携带者的大型国际联盟的数百名女性的基因型,发现与 CNJ 女性相比,AJ 女性表现出长程单倍型。携带 BRCA1 185delAG 突变的 AJ 染色体中超过 50%共享相同的 2.1 Mb 单倍型,携带 BRCA2 6174delT 突变的 AJ 染色体中近 16%共享 1.4 Mb 单倍型。基于对阿什肯纳兹人群人口统计学的最佳推断进行的模拟表明,在全基因组调查的背景下,长程单倍型是可以预期的。我们的结果与以下假设一致,即来自人口规模收缩事件的局部瓶颈效应可能偶然导致在阿什肯纳兹犹太人的 BRCA1 和 BRCA2 区域中高频观察到的大单倍型块。

相似文献

1
Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers.阿什肯纳兹犹太裔 BRCA1 和 BRCA2 突变携带者中的单体型结构。
Hum Genet. 2011 Nov;130(5):685-99. doi: 10.1007/s00439-011-1003-z. Epub 2011 May 20.
2
Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer.在患有前列腺癌的加拿大德系犹太人男性中,BRCA1/2基因的始祖突变并不常见。
BMC Med Genet. 2003 Aug 11;4:7. doi: 10.1186/1471-2350-4-7.
3
The 1100delAT BRCA1 and the 8765delAG BRCA2 mutations: occurrence in high-risk non-Ashkenazi Jews and haplotype comparison of Jewish and non-Jewish carriers.1100delAT BRCA1和8765delAG BRCA2突变:在高危非阿什肯纳兹犹太人中的发生情况以及犹太和非犹太携带者的单倍型比较
Fam Cancer. 2004;3(1):11-4. doi: 10.1023/B:FAME.0000026837.32470.b4.
4
Prevalence of nonfounder BRCA1/2 mutations in Ashkenazi Jewish patients presenting for genetic testing at a hereditary breast and ovarian cancer center.在遗传性乳腺癌和卵巢癌中心进行基因检测的阿什肯纳兹犹太裔患者中,非胚系 BRCA1/2 突变的流行率。
Cancer. 2019 Mar 1;125(5):690-697. doi: 10.1002/cncr.31856. Epub 2018 Nov 27.
5
The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women.在阿什肯纳兹女性中,BRCA1基因的185delAG和5382insC以及BRCA2基因的6174delT这几种始祖突变出现在60%的卵巢癌患者和30%的早发性乳腺癌患者中。
Am J Hum Genet. 1997 Mar;60(3):505-14.
6
Incidence of BRCA1 and BRCA2 non-founder mutations in patients of Ashkenazi Jewish ancestry.阿什肯纳兹犹太裔患者中BRCA1和BRCA2非始祖突变的发生率。
Breast Cancer Res Treat. 2015 Jan;149(1):223-7. doi: 10.1007/s10549-014-3218-x. Epub 2014 Dec 6.
7
Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families.在阿什肯纳兹族乳腺癌和卵巢癌家族中未发现基因组 BRCA1 和 BRCA2 重排。
Breast Cancer Res Treat. 2010 Sep;123(2):581-5. doi: 10.1007/s10549-010-0818-y. Epub 2010 Mar 11.
8
Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.携带BRCA1和BRCA2突变的阿什肯纳兹犹太女性患卵巢癌的风险。
Clin Cancer Res. 2002 Dec;8(12):3776-81.
9
Genetic Predisposition to Breast Cancer Due to Mutations Other Than BRCA1 and BRCA2 Founder Alleles Among Ashkenazi Jewish Women.非 BRCA1 和 BRCA2 种系突变导致的阿什肯纳兹犹太裔妇女乳腺癌遗传易感性。
JAMA Oncol. 2017 Dec 1;3(12):1647-1653. doi: 10.1001/jamaoncol.2017.1996.
10
Functional variant of KLOTHO: a breast cancer risk modifier among BRCA1 mutation carriers of Ashkenazi origin.KLOTHO 功能变体:阿什肯纳兹裔 BRCA1 突变携带者的乳腺癌风险修饰因子。
Oncogene. 2010 Jan 7;29(1):26-33. doi: 10.1038/onc.2009.301. Epub 2009 Oct 5.

引用本文的文献

1
Oncogenic BRCA1,2 Mutations in the Human Lineage-A By-Product of Sexual Selection?人类谱系中致癌性BRCA1、2基因突变——性选择的副产品?
Biomedicines. 2023 Dec 21;12(1):22. doi: 10.3390/biomedicines12010022.
2
Development of a Critical Appraisal Tool (AIMRDA) for the Peer-Review of Studies Assessing the Anticancer Activity of Natural Products: A Step towards Reproducibility.开发一种用于评估天然产物抗癌活性研究的同行评审的关键评估工具(AIMRDA):迈向可重复性的一步。
Asian Pac J Cancer Prev. 2022 Jan 2;22(12):3735-3740. doi: 10.31557/APJCP.2021.22.12.3735.
3
Pancreatic cancer pathology viewed in the light of evolution.从进化角度看胰腺癌病理学。
Cancer Metastasis Rev. 2021 Sep;40(3):661-674. doi: 10.1007/s10555-020-09953-z. Epub 2021 Feb 8.
4
Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank.外显子组测序揭示了一个多样化的基于人群的生物库中 BRCA1 和 BRCA2 种系变异的高流行率。
Genome Med. 2019 Dec 31;12(1):2. doi: 10.1186/s13073-019-0691-1.
5
Association between hereditary predisposition to common cancers and congenital multimalformations.常见癌症的遗传易感性与先天性多发畸形之间的关联。
Congenit Anom (Kyoto). 2020 Jan;60(1):22-31. doi: 10.1111/cga.12329. Epub 2019 Mar 12.
6
The Potential Contribution of BRCA Mutations to Early Onset and Familial Breast Cancer in Uzbekistan.BRCA突变对乌兹别克斯坦早发性和家族性乳腺癌的潜在贡献。
Cent Asian J Glob Health. 2016 Dec 21;5(1):228. doi: 10.5195/cajgh.2016.228. eCollection 2016.
7
BRCA Mutations Increase Fertility in Families at Hereditary Breast/Ovarian Cancer Risk.BRCA基因突变增加遗传性乳腺癌/卵巢癌风险家族的生育能力。
PLoS One. 2015 Jun 5;10(6):e0127363. doi: 10.1371/journal.pone.0127363. eCollection 2015.
8
BRCA1 and BRCA2 mutations in ethnic Lebanese Arab women with high hereditary risk breast cancer.黎巴嫩阿拉伯族裔患遗传性高危乳腺癌女性中的BRCA1和BRCA2基因突变
Oncologist. 2015 Apr;20(4):357-64. doi: 10.1634/theoncologist.2014-0364. Epub 2015 Mar 16.
9
Wild-type genotypes of BRCA1 gene SNPs combined with micro-RNA over-expression in mammary tissue leading to familial breast cancer with an increased risk of distant metastases' occurrence.BRCA1基因单核苷酸多态性的野生型基因型与乳腺组织中微小RNA过表达相结合,导致家族性乳腺癌,远处转移发生风险增加。
Med Oncol. 2014 Nov;31(11):255. doi: 10.1007/s12032-014-0255-6. Epub 2014 Oct 2.
10
Reliable in vitro studies require appropriate ovarian cancer cell lines.可靠的体外研究需要合适的卵巢癌细胞系。
J Ovarian Res. 2014 Jun 7;7:60. doi: 10.1186/1757-2215-7-60. eCollection 2014.

本文引用的文献

1
ESTIMATING F-STATISTICS FOR THE ANALYSIS OF POPULATION STRUCTURE.估计用于群体结构分析的F统计量
Evolution. 1984 Nov;38(6):1358-1370. doi: 10.1111/j.1558-5646.1984.tb05657.x.
2
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.常见乳腺癌易感基因等位基因与 BRCA1 和 BRCA2 突变携带者的乳腺癌风险:对风险预测的影响。
Cancer Res. 2010 Dec 1;70(23):9742-54. doi: 10.1158/0008-5472.CAN-10-1907. Epub 2010 Nov 30.
3
Common genetic variants and modification of penetrance of BRCA2-associated breast cancer.常见遗传变异与 BRCA2 相关乳腺癌外显率的修饰。
PLoS Genet. 2010 Oct 28;6(10):e1001183. doi: 10.1371/journal.pgen.1001183.
4
Signatures of founder effects, admixture, and selection in the Ashkenazi Jewish population.阿什肯纳兹犹太人群体中的奠基者效应、混合和选择的特征。
Proc Natl Acad Sci U S A. 2010 Sep 14;107(37):16222-7. doi: 10.1073/pnas.1004381107. Epub 2010 Aug 26.
5
Abraham's children in the genome era: major Jewish diaspora populations comprise distinct genetic clusters with shared Middle Eastern Ancestry.基因组时代的亚伯拉罕的子民:主要的犹太散居人群包含具有中东血统的独特遗传簇。
Am J Hum Genet. 2010 Jun 11;86(6):850-9. doi: 10.1016/j.ajhg.2010.04.015.
6
An analysis pipeline for genome-wide association studies.一种用于全基因组关联研究的分析流程。
Cancer Inform. 2008;6:455-61. doi: 10.4137/cin.s966. Epub 2008 Sep 24.
7
Analysis of genetic variation in Ashkenazi Jews by high density SNP genotyping.通过高密度单核苷酸多态性基因分型分析德系犹太人的基因变异。
BMC Genet. 2008 Feb 5;9:14. doi: 10.1186/1471-2156-9-14.
8
The BRCA1 Ashkenazi founder mutations occur on common haplotypes and are not highly correlated with anonymous single nucleotide polymorphisms likely to be used in genome-wide case-control association studies.BRCA1 阿什肯纳兹始祖突变发生在常见单倍型上,与可能用于全基因组病例对照关联研究的匿名单核苷酸多态性相关性不高。
BMC Genet. 2007 Oct 4;8:68. doi: 10.1186/1471-2156-8-68.
9
An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA).一项旨在识别BRCA1和BRCA2突变携带者癌症风险基因修饰因子的国际倡议:BRCA1和BRCA2修饰因子研究联盟(CIMBA)。
Breast Cancer Res. 2007;9(2):104. doi: 10.1186/bcr1670.
10
Convergent adaptation of human lactase persistence in Africa and Europe.人类乳糖酶持久性在非洲和欧洲的趋同适应。
Nat Genet. 2007 Jan;39(1):31-40. doi: 10.1038/ng1946. Epub 2006 Dec 10.